Diabetes Board decisions

The veteran's diabetes mellitus is rated at 40 percent, and his service-connected peripheral vascular disease is found to be secondary to the diabetes mellitus. The Board grants these claims.

The Board has found no evidence linking the veteran's melanoma of the left eye to his military service or exposure to Agent Orange, and thus denied service connection for this condition.

The veteran's appeal is being remanded for further development regarding his claim of service connection for diabetes mellitus due to exposure to Agent Orange at Kadena Air Force Base in Japan.

The Board has ordered additional development due to the need for records from VA medical centers and private doctors, as well as clarification of service connection theory.

The Board has determined that the veteran did not incur cardiomyopathy or diabetes mellitus in service and these conditions are not otherwise related to service. Therefore, both claims for service connection have been denied.

The Board denied the veteran's claim for authorization of special mode transportation benefits due to lack of medical need as defined by VA guidelines, despite his service-connected disabilities and blindness.

The Board has determined that the veteran's service-connected diabetes mellitus contributed to cause his cerebrovascular accident, and therefore grants service connection for residuals of a cerebrovascular accident as secondary to service-connected diabetes.

The Board has reopened the claim for service connection for hearing loss and granted it. The claim for diabetes mellitus was denied as there is no current evidence of the disability.

The Board is remanding the case for additional development to address new and material evidence claims, exposure to herbicides during service, and other procedural issues.

The Board has determined that the veteran's diabetes mellitus is presumed to have been incurred due to herbicide exposure during service in Vietnam. As a result, the claim for service connection is granted.

The Board has determined that the veteran's diabetes mellitus, type II, currently rated at 20 percent, does not warrant a higher rating as his activities have not been restricted due to medical advice.

The veteran's diabetes mellitus, type II, is rated at 40 percent. Right ear hearing loss was found to be incurred in service. Left ear hearing loss was not found to be incurred or aggravated by service.

The veteran's claims for increased ratings and service connection were denied. The denial of the diabetes rating claim is based on the fact that insulin has not yet been prescribed, which is a critical factor for a higher rating.

The Board denied the veteran's claims for service connection for diabetes mellitus, bilateral upper and lower extremity peripheral neuropathy, and diabetic retinopathy. The claim for reopening of the diabetes mellitus was granted.

The Board denied the veteran's claims for increased rating for diabetes mellitus, did not reopen his claim of service connection for bilateral hearing loss due to lack of new and material evidence, and found that tinnitus was not incurred in or aggravated by service.

The veteran's claim for tinnitus as a direct basis is denied.,Service connection for diabetes mellitus, depression, hypothyroidism, an autoimmune system condition, and arthritis are all denied as secondary to service-connected alopecia areata and medications.

The Board has remanded the case due to new evidence and VCAA notification requirements.

The Board has granted a 20 percent disability rating for the veteran's Type II diabetes mellitus, effective from the date of his claim.

The veteran's claims for an increased rating for diabetes mellitus, service connection for PTSD, and a skin rash secondary to herbicide exposure were all denied. The veteran was not diagnosed with PTSD or a current skin condition related to his military service.